New

North America Ocular Drug Delivery Market

2021

Pharmaceuticals North America Ocular Drug Delivery ...

North America Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025761 | No. of Pages: 147 | Category: Pharmaceuticals | Status: Published

Market Insights

North America Ocular Drug Delivery Market to Grow at a CAGR of 7.8% to reach US$ 10,622.77 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The ocular drug delivery market in North America is expected to grow to US$ 10,622.77 million by 2028 from US$ 6,286.54 million in 2021. The market is estimated to grow at a CAGR of 7.8% from 2021 to 2028.


Cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and unaddressed refractive error are among the leading causes of blindness or low vision. Most of the population have or had some eye disorder in their lifetime. As per the World Health Organization (WHO) report "Blindness and vision impairment" published in February 2021, around 2.2 billion people worldwide have a near or distance vision impairment. It has also estimated that the leading cause of vision loss or low vision is cataract (94 million) and uncorrected refractive errors (88.4 million). Further, the other common causes of vision loss are glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million). According to the National Eye Institute (NEI), in the US, the number of people with cataracts is expected to double from 24.4 million in 2010 to about 50 million in 2050. Similarly, as per the Factsheet Glaucoma: Facts & Figures 2019, over 3 million people in the US were living with glaucoma. Moreover, as per the Canadian Survey on Disabilities 2017, 1.5 million Canadians had a sight loss, and around 5.59 million had an eye disease which could further lead to sight loss.

Amidst the COVID-19 crisis, the healthcare institutions have witnessed decrees in inpatient visits to clinics to prevent the spread of the COVID-19 in the first and second quarters of 2020. As per the recent study by CDC, the number of medical emergency department (ED) visits has declined 42% during the early COVID-19. As a result, the number of elective eye procedures performed per week in hospitals and clinics has decreased over time. According to an article in Ophthalmology Times, elective procedures have decreased in countries such as the United States. The number of patient visits to examination facilities has reduced by 15%. During the COVID-19 pandemic, ophthalmology lost a considerable share of patient volume; the volume of ophthalmic practice is predicted to have decreased by 81%, owing to a decline in patients seeking care for glaucoma and cataracts surgery.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The North America ocular drug delivery market is expected to grow at a good CAGR during the forecast period.
North America ocular drug delivery market

Get more information on this report :


North America Ocular Drug Delivery Market Segmentation

North America Ocular Drug Delivery Market – By Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Others

North America Ocular Drug Delivery Market – By Formulation Type

  • Solution
  • Ointment
  • Suspension
  • Emulsion
  • Liposomes and Nanoparticles

North America Ocular Drug Delivery Market – By Disease type

  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Others

North America Ocular Drug Delivery Market – By End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

North America Ocular Drug Delivery Market – By Country

  • US
  • Canada
  • Mexico

North America Ocular Drug Delivery Market – Companies Mentioned

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Clearside Biomedical, Inc
  • Ocular Therapeutix, Inc.
  • Envisia Therapeutics
  • Alimera Sciences, Inc.
  • EYEGATE PHARMACEUTICALS, INC

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Ocular Drug Delivery Market – By Technology

1.3.2 North America Ocular Drug Delivery Market – By Formulation Type

1.3.3 North America Ocular Drug Delivery Market – By Disease Type

1.3.4 North America Ocular Drug Delivery Market – By End User

1.3.5 North America Ocular Drug Delivery Market – By Country

2. North America Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Ocular Drug Delivery – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. North America Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Elevating Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Limitations Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Expansion Awareness About Vision Care

5.4 Future Trends

5.4.1 Thriving of Innovative Products

5.5 Impact analysis

6. North America Ocular Drug Delivery – Market Analysis

6.1 North America Ocular Drug Delivery Market Revenue Forecast and Analysis

7. North America Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. North America Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. North America Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. North America Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. North America Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2 US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.3 US: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.4 US: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.5 US: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.2 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2 Canada Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.3 Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.4 Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.5 Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.3 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2 Mexico Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.3 Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.4 Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.5 Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on North America Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Ocular Therapeutix, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Envisia Therapeutics

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Novartis AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 EYEGATE PHARMACEUTICALS, INC

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Clearside Biomedical, Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. US Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)

Table 3. US Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)

Table 4. US Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done By Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. North America Ocular Drug Delivery Market Segmentation

Figure 2. North America Ocular Drug Delivery Market Segmentation, By Country

Figure 3. North America Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America Ocular Drug Delivery Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. North America Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. North America: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)

Figure 34. North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35. US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Impact of COVID-19 Pandemic in North American Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                      
  5. Ocular Therapeutix, Inc.                       
  6. Envisia Therapeutics                             
  7. Alimera Sciences, Inc.                           
  8. EYEGATE PHARMACEUTICALS, INC                                                            
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in North America ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
TIPRE00025761
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved